Opus Genetics Inc.

IRD | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.67

+$0.02 (+0.55%)

At close: Oct 30, 2026, 4:00 PM ET

$3.73

+$0.06 (+1.63%)

Pre-market: Nov 2, 2026, 7:31 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $305.33M

Enterprise Value $251.45M

Beta 0.62

Average Volume 2.12M

Shares Outstanding (Diluted) 111.38M

Shares Change YoY 75.75%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US67577R1023

Price Performance

Price Change 1M -24.2%

Price Change 3M -1.1%

Price Change 6M -28.6%

Price Change YTD 82.6%

Price Change 1Y 59.6%

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -29.1%

1Y CAGR (ann.) 85.3%

5Y CAGR (ann.) N/A

All-Time CAGR 64.7%

Valuation

PE Ratio -2.89

Forward PE N/A

PEG Ratio 0.07

Forward PEG -0.05

PS Ratio 30.98

Forward PS 25.60

PB Ratio -23.51

P/FCF Ratio -7.51

P/Adj. FCF Ratio -6.77

P/OCF Ratio -8.53

EV/Sales 25.51

EV/EBIT -2.40

EV/EBITDA -2.40

EV/FCF -6.18

Earnings Yield -34.6%

FCF Yield -13.3%

Adj. FCF Yield -14.8%

Financial Health

Net Cash $53.88M

Total Debt $34.93M

Cash & Short-Term Investments $88.81M

Total Assets $92.97M

Current Ratio 12.19

Quick Ratio 12.19

Debt / Equity Ratio -2.69

Debt / EBITDA -0.33

Debt / FCF -0.86

OCF / Debt -1.16

Interest Coverage -19.11

Altman Z-Score -4.74

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 99.9%

Operating Profit Margin -513.5%

EBITDA Margin -1064.4%

Net Profit Margin -1091.8%

FCF Margin -412.6%

Adj. FCF Margin -457.9%

SBC / Revenue 45.3%

SBC Impact (per share) -11.0%

Returns

Return on Assets -115.8%

Return on Equity 1147.6%

Return on Invested Capital -59.3%

Return on Capital Employed -59.3%

Return on Tangible Assets -115.8%

Historical Growth (CAGR)

Revenue CAGR 3Y -39.8%

Revenue CAGR 5Y 150.5%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -29.7%

EPS CAGR 5Y -34.7%

EPS CAGR 10Y N/A

FCF CAGR 3Y -52.2%

FCF CAGR 5Y -59.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y 31.2%

Revenue Growth Next 3Y 113.3%

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.14

EPS Growth Est (next Q) -44.0%

Revenue Est (next Q) $1.55M

Revenue Growth Est (next Q) -49.8%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $12.60

Price Target Upside 243.3%

Cash Flow

Operating Cash Flow $-40.67M

Free Cash Flow $-40.67M

Adj. Free Cash Flow $-45.13M

FCF Per Share -$0.43

OCF Per Share -$0.43

OCF/S Ratio -412.6%

Income Statement

Revenue $9.86M

Gross Profit $9.84M

Operating Income $-50.61M

EBITDA $-104.92M

Net Income $-107.61M

EPS (Diluted) -$1.27

Revenue / Employee $352K

Profit / Employee $-3.84M

Employees 28